25 May 2013
Keywords: smithkline, beecham, files, approval, new, quinolone, filed
Article | 16 December 1999
SmithKline Beecham has filed its first marketing application for a newantibiotic tipped as a successor to the firm's big-selling Augmentin
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 December 1999
24 May 2013
© 2013 thepharmaletter.com